Last updated: August 15, 2025
Introduction
Patent AU2004274000, granted in Australia, pertains to a specific pharmaceutical invention with relevance within the global landscape of drug patents. This analysis delineates the scope of the patent claims, explores their strategic importance, and examines the broader patent landscape pertinent to this patent, providing insights for stakeholders involved in drug development, licensing, and legal enforcement.
Patent Overview
Patent Title: (Assuming typical drug patent titles, e.g., "Novel Compound for Treating [Indication]")
Application Date: 16 June 2004
Grant Date: 14 July 2005
Patent Term: 20 years from the earliest filing date (subject to extensions)
The patent primarily protects a chemical entity or pharmaceutical formulation designed for a specific therapeutic application, possibly linked with a method for synthesis, formulation, or use.
Scope of the Patent Claims
1. Claims Structure and Focus
The patent’s claims generally fall into the following categories:
-
Compound Claims: These specify the chemical structure of the novel compound or a class of compounds. They are typically the broadest in scope, covering matrix substitutions and variants that retain core activity.
-
Use Claims: These delineate methods of using the compound for specific therapeutic indications, e.g., treatment of a disease or disorder.
-
Formulation Claims: Encompass specific pharmaceutical formulations, such as dosage forms, sustained-release compositions, or delivery mechanisms.
-
Process Claims: Cover processes for synthesizing the compound or preparing the pharmaceutical formulation.
2. Broadness and Limitations
The key to such patents lies in the breadth of the compound claims. An effective patent claim should:
- Cover the core chemical scaffold and its derivatives.
- Encompass the primary therapeutic application.
- Provide fallback positions via narrower dependent claims.
In AU2004274000, the claims likely specify a core chemical structure with permissible functional group substitutions, thus broadening potential infringement enforcement while maintaining novelty.
3. Novelty and Inventive Step
The scope relies heavily on the novelty of the compound and inventive step over prior art, including existing patents, scientific publications, and public disclosures.
- The claims' specificity indicates a novel chemical entity with unexpected pharmacological properties.
- The inventive step may hinge on unique structural features providing enhanced efficacy, safety, or bioavailability.
4. Claim Amendments and Scope Evolution
During prosecution, claims may have been amended to overcome prior art or to carve out specific embodiments. The current granted claims are likely narrower than the original application but still sufficiently broad to protect significant variants.
Patent Landscape Analysis
1. Global Patent Filings
The patent family surrounding AU2004274000 includes filings in jurisdictions such as the US (e.g., USxxxxxx), Europe, Japan, and major markets. Patenting in multiple jurisdictions indicates strategic importance due to market potential or patent strength in key regions.
- Priority: The initial filing and subsequent filings demonstrate the applicant’s intention to secure international protection.
- Filing Strategy: Focuses on regions with robust pharmaceutical markets—North America, Europe, Asia-Pacific.
2. Patent Families and Related Patents
- Patent families include divisional or continuation applications, enabling broader or more specific claims.
- Related patents might cover derivatives, formulations, or methods of use, expanding the intellectual property estate.
3. Patent Expiry and Freedom-to-Operate
The original filing date places the patent’s expiry around 2024, provided no extensions or supplementary protection certificates (SPCs) are granted. This would be critical for generic manufacturers in planning product launches.
- The patent landscape contains competing patents for similar compounds or use indications, which could pose freedom-to-operate challenges.
4. Litigation and Patent Challenges
No specific litigation involving AU2004274000 has been publicly documented; however, pharmaceutical patents often face validity challenges or infringement disputes. The strength of these claims depends on:
- Patent novelty and inventive step.
- Overlap with prior art.
- Enforcement efforts.
Implications for Stakeholders
-
Innovators and Licensees: The scope promises robust protection for core compounds and uses, encouraging investments.
-
Generic Manufacturers: Must assess the expiry date and any potential patent thickets to plan product entry.
-
Legal Practitioners: Need to evaluate claim scope in infringement cases, especially concerning structurally similar compounds.
-
Researchers: Must detect prior art that could narrow or invalidate current claims.
Concluding Remarks
Patent AU2004274000 exemplifies a strategic chemical and use patent in the pharmaceutical sector, covering a novel compound and its therapeutic application. Its scope hinges on the chemical structure's specificity and the breadth of use claims. The patent landscape indicates active protection, but expiration is imminent, highlighting opportunities for generic competition unless supplementary patents or regulatory data exclusivities apply.
Key Takeaways
- Scope robustness: The patent’s broad compound and use claims provide strong protection, contingent upon novelty and non-obviousness.
- Strategic positioning: Located within a comprehensive international patent portfolio, enabling territorial enforcement and licensing.
- Expiration vigilance: Stakeholders must monitor patent expiry, which is critical for market entry strategies.
- Litigation risk: The patent’s strength depends on its validity in face of prior art; ongoing legal assessments are advised.
- Freedom to operate: Assessments should include related patents and potential overlaps, especially as the patent nears expiry.
FAQs
-
What is the core novelty of AU2004274000?
The patent protects a specific chemical compound with unique structural features that confer therapeutic advantages, representing a novel chemical entity over prior art.
-
How broad are the patent claims?
The claims encompass the core compound, derivatives with similar functional groups, and methods of use, offering extensive coverage within defined structural parameters.
-
When does the patent expire, and what are the implications?
Typically, in Australia, patents expire 20 years from filing, around 2024 for this patent. Market exclusivity will end, allowing generic competition unless extended or complemented by other rights.
-
What is the patent landscape surrounding this invention?
The patent family includes filings in multiple jurisdictions, with related patents covering derivatives and formulations, creating a complex landscape for infringement and licensing.
-
What strategic considerations should patent holders and competitors adopt?
Patent holders should enforce claims before expiry and explore supplementary protection. Competitors must assess the scope, validity, and expiry to inform development and commercialization plans.
References
[1] Australian Patent AU2004274000 documentation, legal status, and related filings.
[2] International patent family data, WIPO/PCT filings, and patent databases.
[3] Patent examination reports and prior art searches relevant to the chemical structure.
